Oncolytics Biotech® Inc. (NASDAQ: ONCY), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced that the first patient was ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE